Suchergebnisse - "Podzamczer, Daniel"

PubPharm (24)

1

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Podzamczer, D. | Imaz, A. | Lopez-Lirola, A. | +25

2

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

enthalten in: The Journal of infectious diseases | 2023

von Scévola, S. | Niubó, J. | Domingo, P. | +10

3

Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

enthalten in: Biochemical pharmacology | 2021

von Vigón, L. | Martínez-Román, P. | Rodríguez-Mora, S. | +27

4

Acute inflammatory demyelinating polyneuropathy following interruption of antiretroviral treatment and HIV rebound

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Malano, D. | Tiraboschi, J. | Saumoy, M. | +1

5

Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy : Comparison with a healthy control group in a 2-year prospective study

enthalten in: PloS one | 2020

von Di Yacovo, S. | Saumoy, M. | Sánchez-Quesada, J. | +10

6

Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Imaz, A. | Niubó, J. | Cottrell, M. | +6

7

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2019

von AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan: | Pérez-Molina, J. | Polo, R. | +41

8

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults : a randomised, double-blind, active-controlled, non-inferiority phase 3 trial

enthalten in: The lancet. HIV | 2018

von Winston, A. | Post, F. | DeJesus, E. | +14

CommentIn: Lancet HIV. 2018 Apr;5(4):e156-e157. - PMID 29475803

9

Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2018

von Llibre, J. | de Lazzari, E. | Molina, J. | +7

10

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489) : a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

enthalten in: Lancet (London, England) | 2017

von Gallant, J. | Lazzarin, A. | Mills, A. | +14